Logo image of ACAD

ACADIA PHARMACEUTICALS INC (ACAD) Stock Analyst Earnings Estimates

NASDAQ:ACAD - Nasdaq - US0042251084 - Common Stock - Currency: USD

23.97  +0.44 (+1.87%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ACAD revenue by date.ACAD revenue by date.
517.2M
6.84%
726.437M
40.46%
957.797M
31.85%
1.085B
13.28%
1.203B
10.88%
1.354B
12.55%
1.516B
11.96%
1.673B
10.36%
1.565B
-6.46%
1.804B
15.27%
1.951B
8.15%
EBITDA
YoY % growth
ACAD ebitda by date.ACAD ebitda by date.
-221.57M
-32.64%
-67.447M
69.56%
99.883M
248.09%
87.51M
-12.39%
167.65M
91.58%
350.45M
109.04%
662.3M
88.99%
873.97M
31.96%
N/AN/AN/A
EBIT
YoY % growth
ACAD ebit by date.ACAD ebit by date.
-223.6M
-31.22%
-73M
67.35%
84M
215.07%
89.318M
6.33%
144.12M
61.36%
254.29M
76.44%
437.92M
72.21%
578.36M
32.07%
432.15M
-25.28%
596.57M
38.05%
798.83M
33.90%
Operating Margin
ACAD operating margin by date.ACAD operating margin by date.
-43.23%-10.05%8.77%8.23%11.98%18.78%28.89%34.57%27.61%33.07%40.94%
EPS
YoY % growth
ACAD eps by date.ACAD eps by date.
-0.97
7.62%
-0.38
60.82%
0.48
226.32%
0.53
11.46%
0.85
58.73%
1.59
87.79%
2.42
51.70%
3.04
25.65%
2.88
-5.26%
3.95
37.07%
5.18
31.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
0.14
-29.85%
0.14
-29.91%
0.13
750.40%
0.07
-35.09%
Revenue
Q2Q % growth
267.12M
10.40%
279.68M
11.69%
289.43M
11.49%
273.55M
11.97%
EBITDA
Q2Q % growth
23.478M
-38.38%
21.571M
-49.44%
21.859M
-4.47%
N/A
EBIT
Q2Q % growth
22.382M
-25.39%
22.86M
-28.56%
20.423M
191.76%
10.702M
-43.67%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
0.11
10.00%
0.110.00-3.19%
Q4 2024
Q2Q % growth
-0.02
-107.14%
0.22-0.24-109.07%
Q3 2024
Q2Q % growth
0.20
150.00%
0.140.0641.97%
Q2 2024
Q2Q % growth
0.20
1,900.00%
0.180.029.83%
Q1 2024
Q2Q % growth
0.10
137.04%
0.050.05109.49%
Q4 2023
Q2Q % growth
0.28
207.69%
0.31-0.03-9.66%
Q3 2023
Q2Q % growth
-0.40
-135.29%
-0.430.037.97%
Q2 2023
Q2Q % growth
0.01
104.76%
-0.080.09111.87%
Q1 2023
Q2Q % growth
-0.27
18.18%
-0.22-0.05-23.29%
Q4 2022
Q2Q % growth
-0.26
3.70%
-0.25-0.01-4.94%
Q3 2022
Q2Q % growth
-0.17
-88.89%
-0.190.0212.05%
Q2 2022
Q2Q % growth
-0.21
22.22%
-0.250.0416.87%
Q1 2022
Q2Q % growth
-0.33
21.43%
-0.610.2846.18%
Q4 2021
Q2Q % growth
-0.27
35.71%
-0.24-0.03-11.34%
Q3 2021
Q2Q % growth
-0.09
83.33%
-0.270.1866.19%
Q2 2021
Q2Q % growth
-0.27 -0.310.0413.13%
Q1 2021
Q2Q % growth
-0.42
26.32%
-0.540.1222.52%
Q4 2020
Q2Q % growth
-0.42
-23.53%
-0.480.0612.68%
Q3 2020
Q2Q % growth
-0.54
-86.21%
-0.39-0.15-38.11%
Q2 2020
Q2Q % growth
-0.27
28.95%
-0.450.1840.17%
Q1 2020
Q2Q % growth
-0.57
3.39%
-0.49-0.08-16.35%
Q4 2019
Q2Q % growth
-0.34 -0.370.038.14%
Q3 2019
Q2Q % growth
-0.29 -0.410.1229.19%
Q2 2019
Q2Q % growth
-0.38 -0.460.0818.04%
Q1 2019
Q2Q % growth
-0.59 -0.54-0.05-10.27%
ACAD Yearly EPS VS EstimatesACAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
244.317M
18.70%
244.12M197K0.08%
Q4 2024
Q2Q % growth
259.602M
12.36%
283.2M-23.598M-8.33%
Q3 2024
Q2Q % growth
250.401M
18.28%
253.79M-3.389M-1.34%
Q2 2024
Q2Q % growth
241.963M
46.44%
240.37M1.593M0.66%
Q1 2024
Q2Q % growth
205.831M
73.75%
212.46M-6.629M-3.12%
Q4 2023
Q2Q % growth
231.041M
69.26%
228.26M2.781M1.22%
Q3 2023
Q2Q % growth
211.699M
61.97%
193.28M18.419M9.53%
Q2 2023
Q2Q % growth
165.235M
22.76%
160.96M4.275M2.66%
Q1 2023
Q2Q % growth
118.462M
2.56%
122.69M-4.228M-3.45%
Q4 2022
Q2Q % growth
136.5M
4.36%
136.75M-250K-0.18%
Q3 2022
Q2Q % growth
130.7M
-0.68%
141.42M-10.72M-7.58%
Q2 2022
Q2Q % growth
134.6M
16.84%
133.04M1.56M1.17%
Q1 2022
Q2Q % growth
115.5M
8.35%
124.35M-8.85M-7.12%
Q4 2021
Q2Q % growth
130.8M
8.10%
138.1M-7.3M-5.29%
Q3 2021
Q2Q % growth
131.6M
9.12%
130.31M1.29M0.99%
Q2 2021
Q2Q % growth
115.2M
4.63%
127.44M-12.24M-9.60%
Q1 2021
Q2Q % growth
106.6M
18.31%
113.87M-7.27M-6.38%
Q4 2020
Q2Q % growth
121M
23.09%
125.67M-4.67M-3.72%
Q3 2020
Q2Q % growth
120.6M
27.48%
121.2M-600K-0.50%
Q2 2020
Q2Q % growth
110.1M
32.33%
105.41M4.69M4.45%
Q1 2020
Q2Q % growth
90.1M
43.02%
92.894M-2.794M-3.01%
Q4 2019
Q2Q % growth
98.3M 98.698M-398K-0.40%
Q3 2019
Q2Q % growth
94.6M 90.257M4.343M4.81%
Q2 2019
Q2Q % growth
83.2M 73.568M9.632M13.09%
Q1 2019
Q2Q % growth
63M 61.901M1.099M1.78%
ACAD Yearly Revenue VS EstimatesACAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.45% -16.19% -5.03% -19.16%
Revenue-0.2% -0.63% -0.09% 0.18%